PFM Health Sciences, LP
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 1442756
SAN FRANCISCO, CA
Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,914,524
+$1,496,755 QoQ
Shares Held
38,575
+8.9% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#79
of 308 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. PRAX ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
233,171 | $62,191,369 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
219,596 | $53,750,512 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,768 | $38,740,264 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
308,385 | $29,219,478 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
143,222 | $26,822,616 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
253,358 | $18,870,103 | |
| 7 | CYTK |
Cytokinetics Inc
|
191,686 | $16,329,730 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,313 | $15,739,615 |
All Filings in PRAX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,914,524 | 38,575 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,417,769 | 35,438 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,184,982 | 31,163 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,210,634 | 60,578 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,562,181 | 84,713 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,091,995 | 160,866 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,197,412 | 119,509 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,535,113 | 183,092 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,742,118 | 453,146 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,143,457 | 477,605 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $14,627,889 | 656,548 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $15,253,194 | 8,919,997 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,225,526 | 8,891,762 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,760,864 | 2,176,594 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,610,371 | 2,777,467 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,850,851 | 3,458,525 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,078,500 | 3,297,347 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,829,801 | 864,819 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,527,308 | 635,904 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,419,865 | 455,374 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,324,236 | 455,374 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||